Literature DB >> 20583210

Conditional beta-catenin loss in mice promotes chemical hepatocarcinogenesis: role of oxidative stress and platelet-derived growth factor receptor alpha/phosphoinositide 3-kinase signaling.

Xu-Feng Zhang1, Xinping Tan, Gang Zeng, Amalea Misse, Sucha Singh, Youngsoo Kim, James E Klaunig, Satdarshan P S Monga.   

Abstract

UNLABELLED: Activation of beta-catenin, the central effector of the canonical Wnt pathway and a recognized oncogene, has been implicated in hepatocellular carcinoma. We examined N-nitrosodiethylamine (DEN)-induced tumorigenesis in hepatic beta-catenin conditional knockout mice (beta-cat KO). Male beta-cat KO and age- and sex-matched littermate controls were given a single intraperitoneal DEN injection and followed for 6-12 months for hepatic tumors. Hepatic tumors were characterized for histology, proliferation, apoptosis, oxidative stress, and specific proteins by way of western blot, immunohistochemistry, and coprecipitation studies. For in vivo tumor intervention studies, specific inhibitors were administered intraperitoneally or through drinking water. Intriguingly, beta-cat KO mice showed a paradoxical increase in susceptibility to DEN-induced tumorigenesis. This accelerated tumorigenesis is due to increased injury and inflammation, unrestricted oxidative stress, fibrosis, and compensatory increase in hepatocyte proliferation secondary to platelet-derived growth factor receptor alpha (PDGFRalpha)/phosphoinositide 3-kinase (PIK3CA)/Akt activation and c-Myc overexpression. In vitro suppression of beta-catenin expression in hepatoma cells led to enhanced PDGFRalpha expression, which was abrogated in the presence of nuclear factor kappaB (NF-kappaB) inhibitor. Daily treatment of 6-month-old DEN-exposed beta-cat KO with PDGFRalpha inhibitor dramatically reduced tumor numbers and size. Inclusion of N-acetyl-L-cysteine, a known antioxidant and NF-kappaB inhibitor, in the drinking water led to complete abolition of tumorigenesis in DEN-exposed beta-cat KO.
CONCLUSION: Loss of beta-catenin impairs the liver's ability to counteract DEN-induced oxidative stress and enhances tumorigenesis through PDGFRalpha/PIK3CA/Akt signaling. Blockade of PDGFRalpha or oxidative stress dramatically affects beta-catenin-deficient tumorigenesis. Also, hepatoma cells use PDGFRalpha/PIK3CA signaling as an escape mechanism following beta-catenin suppression, and their sequential suppression profoundly impedes tumor proliferation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20583210      PMCID: PMC3100799          DOI: 10.1002/hep.23747

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  51 in total

Review 1.  Hepatocellular carcinoma pathogenesis: from genes to environment.

Authors:  Paraskevi A Farazi; Ronald A DePinho
Journal:  Nat Rev Cancer       Date:  2006-09       Impact factor: 60.716

2.  Liver-specific loss of beta-catenin results in delayed hepatocyte proliferation after partial hepatectomy.

Authors:  Shigeki Sekine; Pedro J A Gutiérrez; Billy Yu-Ang Lan; Sandy Feng; Matthias Hebrok
Journal:  Hepatology       Date:  2007-02       Impact factor: 17.425

3.  TGF-beta1 induces COX-2 expression and PGE2 synthesis through MAPK and PI3K pathways in human mesangial cells.

Authors:  A Rodríguez-Barbero; F Dorado; S Velasco; A Pandiella; B Banas; J M López-Novoa
Journal:  Kidney Int       Date:  2006-07-05       Impact factor: 10.612

4.  Conditional deletion of beta-catenin reveals its role in liver growth and regeneration.

Authors:  Xinping Tan; Jaideep Behari; Benjamin Cieply; George K Michalopoulos; Satdarshan P S Monga
Journal:  Gastroenterology       Date:  2006-11       Impact factor: 22.682

Review 5.  Genomics and signaling pathways in hepatocellular carcinoma.

Authors:  Augusto Villanueva; Philippa Newell; Derek Y Chiang; Scott L Friedman; Josep M Llovet
Journal:  Semin Liver Dis       Date:  2007-02       Impact factor: 6.115

6.  Loss of hepatocyte growth factor/c-Met signaling pathway accelerates early stages of N-nitrosodiethylamine induced hepatocarcinogenesis.

Authors:  Taro Takami; Pal Kaposi-Novak; Koichi Uchida; Luis E Gomez-Quiroz; Elizabeth A Conner; Valentina M Factor; Snorri S Thorgeirsson
Journal:  Cancer Res       Date:  2007-10-15       Impact factor: 12.701

7.  Transglutaminase 2 and NF-kappaB interplay during NGF-induced differentiation of neuroblastoma cells.

Authors:  Salvatore Condello; Daniela Caccamo; Monica Currò; Nadia Ferlazzo; Giulia Parisi; Riccardo Ientile
Journal:  Brain Res       Date:  2008-02-29       Impact factor: 3.252

8.  Beta-catenin deletion in hepatoblasts disrupts hepatic morphogenesis and survival during mouse development.

Authors:  Xinping Tan; Youzhong Yuan; Gang Zeng; Udayan Apte; Michael D Thompson; Benjamin Cieply; Donna B Stolz; George K Michalopoulos; Klaus H Kaestner; Satdarshan P S Monga
Journal:  Hepatology       Date:  2008-05       Impact factor: 17.425

Review 9.  Cyclooxygenase-2 (COX-2)--a therapeutic target in liver cancer?

Authors:  Marco Breinig; Peter Schirmacher; Michael André Kern
Journal:  Curr Pharm Des       Date:  2007       Impact factor: 3.116

10.  Platelet-derived growth factor receptor-alpha: a novel therapeutic target in human hepatocellular cancer.

Authors:  Peggy Stock; Dulabh Monga; Xinping Tan; Amanda Micsenyi; Nick Loizos; Satdarshan P S Monga
Journal:  Mol Cancer Ther       Date:  2007-06-29       Impact factor: 6.261

View more
  43 in total

Review 1.  Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad.

Authors:  Kari Nichole Nejak-Bowen; Satdarshan P S Monga
Journal:  Semin Cancer Biol       Date:  2010-12-21       Impact factor: 15.707

2.  Spontaneous repopulation of β-catenin null livers with β-catenin-positive hepatocytes after chronic murine liver injury.

Authors:  Michael D Thompson; Emily D Wickline; William B Bowen; Amy Lu; Sucha Singh; Amalea Misse; Satdarshan P S Monga
Journal:  Hepatology       Date:  2011-07-21       Impact factor: 17.425

3.  Hepatoblastoma modeling in mice places Nrf2 within a cancer field established by mutant β-catenin.

Authors:  Sarah A Comerford; Elizabeth A Hinnant; Yidong Chen; Hima Bansal; Shawn Klapproth; Dinesh Rakheja; Milton J Finegold; Dolores Lopez-Terrada; Kathryn A O'Donnell; Gail E Tomlinson; Robert E Hammer
Journal:  JCI Insight       Date:  2016-10-06

4.  Cell cycle-related kinase links androgen receptor and β-catenin signaling in hepatocellular carcinoma: why are men at a loss?

Authors:  Prince K Awuah; Satdarshan P Monga
Journal:  Hepatology       Date:  2012-03       Impact factor: 17.425

5.  Mice lacking liver-specific β-catenin develop steatohepatitis and fibrosis after iron overload.

Authors:  Morgan E Preziosi; Sucha Singh; Erika V Valore; Grace Jung; Branimir Popovic; Minakshi Poddar; Shanmugam Nagarajan; Tomas Ganz; Satdarshan P Monga
Journal:  J Hepatol       Date:  2017-03-22       Impact factor: 25.083

6.  Dual Shp2 and Pten Deficiencies Promote Non-alcoholic Steatohepatitis and Genesis of Liver Tumor-Initiating Cells.

Authors:  Xiaolin Luo; Rui Liao; Kaisa L Hanley; Helen He Zhu; Kirsten N Malo; Carolyn Hernandez; Xufu Wei; Nissi M Varki; Nazilla Alderson; Catherine Chu; Shuangwei Li; Jia Fan; Rohit Loomba; Shuang-Jian Qiu; Gen-Sheng Feng
Journal:  Cell Rep       Date:  2016-12-13       Impact factor: 9.423

Review 7.  Wnt/β-Catenin Signaling in Liver Development, Homeostasis, and Pathobiology.

Authors:  Jacquelyn O Russell; Satdarshan P Monga
Journal:  Annu Rev Pathol       Date:  2017-11-10       Impact factor: 23.472

Review 8.  Stem cells in liver diseases and cancer: recent advances on the path to new therapies.

Authors:  C Bart Rountree; Lopa Mishra; Holger Willenbring
Journal:  Hepatology       Date:  2012-01       Impact factor: 17.425

9.  Hepatic Stellate Cell-Macrophage Crosstalk in Liver Fibrosis and Carcinogenesis.

Authors:  Michitaka Matsuda; Ekihiro Seki
Journal:  Semin Liver Dis       Date:  2020-04-02       Impact factor: 6.115

10.  Loss of hepatocyte β-catenin protects mice from experimental porphyria-associated liver injury.

Authors:  Harvinder Saggi; Dhiman Maitra; An Jiang; Rong Zhang; Pengcheng Wang; Pamela Cornuet; Sucha Singh; Joseph Locker; Xiaochao Ma; Harry Dailey; Marc Abrams; M Bishr Omary; Satdarshan P Monga; Kari Nejak-Bowen
Journal:  J Hepatol       Date:  2018-10-01       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.